125 related articles for article (PubMed ID: 6253567)
1. Circulating immune complexes associated with naturally occurring lymphosarcoma in pet cats.
Day NK; O'Reilly-Felice C; Hardy WD; Good RA; Witkin SS
J Immunol; 1980 Dec; 125(6):2363-6. PubMed ID: 6253567
[TBL] [Abstract][Full Text] [Related]
2. Hypocomplementemia associated with naturally occurring lymphosarcoma in pet cats.
Kobilinsky L; Hardy WD; Day NK
J Immunol; 1979 Jun; 122(6):2139-42. PubMed ID: 221581
[TBL] [Abstract][Full Text] [Related]
3. Remission of FeLV-associated lymphosarcoma and persistent viral infection after extracorporeal immunoadsorption of plasma using staphylococcal protein A columns: details of immune response.
Snyder HW; Reed DE; Jones FR
Semin Hematol; 1989 Apr; 26(2 Suppl 1):25-30. PubMed ID: 2543084
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of circulating feline leukemia virus-immune complexes from plasma of persistently infected pet cats removed by ex vivo immunosorption.
Snyder HW; Jones FR; Day NK; Hardy WD
J Immunol; 1982 Jun; 128(6):2726-30. PubMed ID: 6281336
[TBL] [Abstract][Full Text] [Related]
5. Association of feline leukemia virus with lymphosarcoma and other disorders in the cat.
Cotter SM; Hardy WD; Essex M
J Am Vet Med Assoc; 1975 Mar; 166(5):449-54. PubMed ID: 163223
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of specific antibodies bound to feline leukemia virus in the plasma of pet cats.
Snyder HW; Singhal MC; Yoshida LH; Jones FR
Mol Immunol; 1985 Aug; 22(8):863-70. PubMed ID: 2995795
[TBL] [Abstract][Full Text] [Related]
7. Clearance of feline leukemia virus from persistently infected pet cats treated by extracorporeal immunoadsorption is correlated with an enhanced antibody response to FeLV gp 70.
Snyder HW; Singhal MC; Hardy WD; Jones FR
J Immunol; 1984 Mar; 132(3):1538-43. PubMed ID: 6319496
[TBL] [Abstract][Full Text] [Related]
8. Influence of thymectomy on the susceptibility of cats to feline leukemia virus and lymphosarcoma.
Hoover EA; Krakowka S; Cockerell GL; Mathes LE; Olsen RG
Am J Vet Res; 1978 Jun; 39(6):993-5. PubMed ID: 208436
[TBL] [Abstract][Full Text] [Related]
9. Course of feline leukemia virus infection and its detection by enzyme-linked immunosorbent assay and monoclonal antibodies.
Lutz H; Pedersen NC; Theilen GH
Am J Vet Res; 1983 Nov; 44(11):2054-9. PubMed ID: 6316819
[TBL] [Abstract][Full Text] [Related]
10. [The incidence of lymphosarcoma (leukaemia) and feline leukaemia virus (FeLV) in cats in the Netherlands (author's transl)].
Weijer K
Tijdschr Diergeneeskd; 1975 Sep; 100(18):976-86. PubMed ID: 169604
[TBL] [Abstract][Full Text] [Related]
11. Development of virus non-producer lymphosarcomas in pet cats exposed to FeLv.
Hardy WD; McClelland AJ; Zuckerman EE; Snyder HW; MacEwen EG; Francis D; Essex M
Nature; 1980 Nov; 288(5786):90-2. PubMed ID: 6253821
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: relation to feline leukemia virus status, tumor site, and patient age.
Jackson ML; Wood SL; Misra V; Haines DM
Can J Vet Res; 1996 Jul; 60(3):199-204. PubMed ID: 8809383
[TBL] [Abstract][Full Text] [Related]
13. Lymphosarcoma and persistent feline leukemia virus infection of pet cats: a system to study responses during extracorporeal treatments.
Jones FR; Grant CK; Snyder HW
J Biol Response Mod; 1984; 3(3):286-92. PubMed ID: 6086847
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of the feline leukemia virus (FeLV).
Hardy WD; McClelland AJ; MacEwen EG; Hess PW; Hayes AA; Zuckerman EE
Cancer; 1977 Apr; 39(4 Suppl):1850-5. PubMed ID: 192437
[TBL] [Abstract][Full Text] [Related]
15. The feline oncornavirus-associated cell membrane antigen (FOCMA) is related to, but distinguishable from, FeLV-C gp70.
Snyder HW; Singhal MC; Zuckerman EE; Jones FR; Hardy WD
Virology; 1983 Dec; 131(2):315-27. PubMed ID: 6318434
[TBL] [Abstract][Full Text] [Related]
16. Immunologic profiles of cats with persistent, naturally acquired feline leukemia virus infection.
Reimann KA; Bull RW; Crow SE; Coffman P; Raskin RE
Am J Vet Res; 1986 Sep; 47(9):1935-9. PubMed ID: 3021028
[TBL] [Abstract][Full Text] [Related]
17. Feline leukaemia virus status of Australian cats with lymphosarcoma.
Gabor LJ; Jackson ML; Trask B; Malik R; Canfield PJ
Aust Vet J; 2001 Jul; 79(7):476-81. PubMed ID: 11549046
[TBL] [Abstract][Full Text] [Related]
18. Circulating antibodies to the feline leukemia virus and FOCMA in cats.
Lizonová A; Grófová M
Neoplasma; 1983; 30(3):281-6. PubMed ID: 6306490
[TBL] [Abstract][Full Text] [Related]
19. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays.
Tandon R; Cattori V; Willi B; Lutz H; Hofmann-Lehmann R
Vet Immunol Immunopathol; 2008 May; 123(1-2):129-33. PubMed ID: 18295344
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of protein A administered intravenously to pet cats with leukemia or lymphosarcoma.
Harper HD; Sjöquist J; Hardy WD; Jones FR
Cancer; 1985 May; 55(9):1863-7. PubMed ID: 2983866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
